| |
Article Title |
Author(s) |
Type (Status) |
Available Online |
|
[18F]-FDG uptake dose–response correlates with radiation pneumonitis in lung cancer patients
DOI: 10.1016/j.radonc.2012.04.003
Abstract: Purpose: To quantify the post-radiotherapy 2-[18F]-fluoro-2-deoxyglucose (FDG) pulmonary uptake dose–response in lung cancer patients and determine its relationship with radiation pneumoniti...
|
Matthew R. McCurdy,
Richard Castillo,
Josue Martinez,
Mohammad Najeeb Al Hallack,
Jessica Lichter,
Nicolas Zouain,
Thomas Guerrero
et al.
|
Full-length article
(In Press Corrected Proof)
|
11 May 2012 |
|
Out-of-field dose studies with an anthropomorphic phantom: Comparison of X-rays and particle therapy treatments
DOI: 10.1016/j.radonc.2012.04.004
Abstract: Background and purpose: Characterization of the out-of-field dose profile following irradiation of the target with a 3D treatment plan delivered with modern techniques. Methods: An anthropom...
|
Chiara La Tessa,
Thomas Berger,
Robert Kaderka,
Dieter Schardt,
Christine Körner,
Ulla Ramm,
Jörg Licher,
Nakahiro Matsufuji,
Christina Vallhagen Dahlgren,
Tony Lomax,
Günther Reitz,
Marco Durante
et al.
|
Full-length article
(In Press Corrected Proof)
|
11 May 2012 |
|
Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans
DOI: 10.1016/j.radonc.2012.03.017
Abstract: Background and purpose: The potentials of lung sparing, dose escalation, and the robustness of intensity modulated proton plans (IMPTrobust), obtained by minimax optimization on multiple sce...
|
Martin Stuschke,
Andreas Kaiser,
Christoph Pöttgen,
Wolfgang Lübcke,
Jonathan Farr
et al.
|
Full-length article
(In Press Corrected Proof)
|
07 May 2012 |
|
Enhanced intrinsic radiosensitivity after treatment with stereotactic radiosurgery for an acoustic neuroma
DOI: 10.1016/j.radonc.2012.03.011
Abstract: Enhanced radiosensitivity is an uncommon phenomenon attributable to deficient DNA repair after radiotherapy which can be assessed with the γ-H2AX assay. Reports of radiosensitivity after ste...
|
Gerard Adams,
Olga A. Martin,
Daniel E. Roos,
Pavel N. Lobachevsky,
Andrew E. Potter,
Andrew C. Zacest,
Eva Bezak,
William M. Bonner,
Roger F. Martin,
Trevor Leong
et al.
|
Short communication
(In Press Corrected Proof)
|
07 May 2012 |
|
A radiosensitizing effect of artesunate in glioblastoma cells is associated with a diminished expression of the inhibitor of apoptosis protein survivin
DOI: 10.1016/j.radonc.2012.03.018
Abstract: Background and purpose: Novel strategies to overcome an irradiation resistant phenotype may help to increase therapeutic efficacy in glioblastoma multiforme. The present study aimed to eluci...
|
Sebastian Reichert,
Vera Reinboldt,
Stephanie Hehlgans,
Thomas Efferth,
Claus Rödel,
Franz Rödel
et al.
|
Full-length article
(In Press Corrected Proof)
|
07 May 2012 |
|
Kinomic profiling approach identifies Trk as a novel radiation modulator
DOI: 10.1016/j.radonc.2012.03.014
Abstract: Background: Ionizing radiation treatment is used in over half of all cancer patients, thus determining the mechanisms of response or resistance is critical for the development of novel treat...
|
John S. Jarboe,
Jerry J. Jaboin,
Joshua C. Anderson,
Somaira Nowsheen,
Jennifer A. Stanley,
Faris Naji,
Rob Ruijtenbeek,
Tianxiang Tu,
Dennis E. Hallahan,
Eddy S. Yang,
James A. Bonner,
Christopher D. Willey
et al.
|
Full-length article
(In Press Corrected Proof)
|
07 May 2012 |
|
Quality assurance in the EORTC 22033–26033/CE5 phase III randomized trial for low grade glioma: The digital individual case review
DOI: 10.1016/j.radonc.2012.04.002
Abstract: Introduction: The phase III EORTC 22033–26033/NCIC CE5 intergroup trial compares 50.4Gy radiotherapy with up-front temozolomide in previously untreated low-grade glioma. We describe the digi...
|
Alysa Fairchild,
Damien C. Weber,
Raquel Bar-Deroma,
Akos Gulyban,
Paul A. Fenton,
Roger Stupp,
Brigitta G. Baumert
et al.
|
Full-length article
(In Press Corrected Proof)
|
04 May 2012 |
|
Depletion of the type 1 IGF receptor delays repair of radiation-induced DNA double strand breaks
DOI: 10.1016/j.radonc.2012.03.009
Abstract: Background and purpose: IGF-1R depletion sensitizes prostate cancer cells to ionizing radiation and DNA-damaging cytotoxic drugs. This study investigated the hypothesis that IGF-1R regulates...
|
Benjamin W. Turney,
Martin Kerr,
Meenali M. Chitnis,
Kunal Lodhia,
Yong Wang,
Johann Riedemann,
Mark Rochester,
Andrew S. Protheroe,
Simon F. Brewster,
Valentine M. Macaulay
et al.
|
Full-length article
(In Press Corrected Proof)
|
01 May 2012 |
|
A prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients
DOI: 10.1016/j.radonc.2012.03.013
Abstract: Background and purpose: Significant tumor shrinkage and weight loss may occur during Intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma (NPC). This study aims to evaluate t...
|
Harry C.Y. Cheng,
Vincent W.C. Wu,
Roger K.C. Ngan,
K.W. Tang,
Charlie C.L. Chan,
K.H. Wong,
S.K. Au,
Dora L.W. Kwong
et al.
|
Full-length article
(In Press Corrected Proof)
|
01 May 2012 |
|
Radiosensitization of renal cell carcinoma in vitro through the induction of autophagy
DOI: 10.1016/j.radonc.2012.04.001
Abstract: Background and purpose: For patients diagnosed with advanced renal cell carcinoma (RCC), there are few therapeutic options. Radiation therapy is predominantly used to treat metastasis and ha...
|
Selvakumar Anbalagan,
Isabel M. Pires,
Christopher Blick,
Mark A. Hill,
David J.P. Ferguson,
Denise A. Chan,
Ester M. Hammond
et al.
|
Full-length article
(In Press Corrected Proof)
|
01 May 2012 |
|
Clinical target volumes in anal cancer: Calculating what dose was likely to have been delivered in the UK ACT II trial protocol
DOI: 10.1016/j.radonc.2012.03.007
Abstract: Purpose: Preliminary results of the UK Anal Cancer Trial (ACT) II trial in squamous cell carcinoma of the anus (SCCA) are promising, but 2-D planning with parallel–opposed fields provoked si...
|
Ajay Aggarwal,
Shiva Gayadeen,
Danny Robinson,
Peter J. Hoskin,
Suzy Mawdsley,
Mark Harrison,
Robert Hughes,
Rob Glynne-Jones
et al.
|
Review article
(In Press Corrected Proof)
|
23 April 2012 |
|
NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: The role of dosimetric and clinical factors
DOI: 10.1016/j.radonc.2012.03.004
Abstract: Purpose: The purpose of this multicentre prospective study was to develop multivariable logistic regression models to make valid predictions about the risk of moderate-to-severe patient-rate...
|
Ivo Beetz,
Cornelis Schilstra,
Arjen van der Schaaf,
Edwin R. van den Heuvel,
Patricia Doornaert,
Peter van Luijk,
Arjan Vissink,
Bernard F.A.M. van der Laan,
Charles R. Leemans,
Henk P. Bijl,
Miranda E.M.C. Christianen,
Roel J.H.M. Steenbakkers,
Johannes A. Langendijk
et al.
|
Full-length article
(In Press Corrected Proof)
|
20 April 2012 |
|
The dose–response of the anal sphincter region – An analysis of data from the MRC RT01 trial
DOI: 10.1016/j.radonc.2012.03.002
Abstract: Purpose: Most studies investigating the dose–response of the rectum focus on rectal bleeding. However, it has been reported that other symptoms such as urgency or sphincter control have a la...
|
Florian Buettner,
Sarah L. Gulliford,
Steve Webb,
Matthew R. Sydes,
David P. Dearnaley,
Mike Partridge
et al.
|
Full-length article
(In Press Corrected Proof)
|
20 April 2012 |
|
EGFR-mediated stimulation of sodium/glucose cotransport promotes survival of irradiated human A549 lung adenocarcinoma cells
DOI: 10.1016/j.radonc.2012.03.008
Abstract: Background and purpose: Solid tumor cells may adapt to an ischemic microenvironment by upregulation of sodium/glucose cotransport (SGLT) in the plasma membrane which supplies the tumor cell ...
|
Stephan M. Huber,
Milan Misovic,
Claus Mayer,
Hans-Peter Rodemann,
Klaus Dittmann
et al.
|
Full-length article
(In Press Corrected Proof)
|
19 April 2012 |
|
The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer
DOI: 10.1016/j.radonc.2012.03.005
Abstract: Purpose: The local site of relapse in non-small cell lung cancer (NSCLC) is primarily located in the high FDG uptake region of the primary tumour prior to treatment. A phase II PET-boost tri...
|
Wouter van Elmpt,
Dirk De Ruysscher,
Anke van der Salm,
Annemarie Lakeman,
Judith van der Stoep,
Daisy Emans,
Eugène Damen,
Michel Öllers,
Jan-Jakob Sonke,
José Belderbos
et al.
|
Full-length article
(In Press Corrected Proof)
|
09 April 2012 |
|
Credentialing of radiotherapy centres for a clinical trial of adaptive radiotherapy for bladder cancer (TROG 10.01)
DOI: 10.1016/j.radonc.2012.03.003
Abstract: Background: Daily variations in bladder filling make conformal treatment of bladder cancer challenging. On-line adaptive radiotherapy with a choice of plans has been demonstrated to reduce s...
|
Tomas Kron,
Daniel Pham,
Paul Roxby,
Aldo Rolfo,
Farshad Foroudi
et al.
|
Full-length article
(In Press Corrected Proof)
|
09 April 2012 |
|
Tumour microenvironment heterogeneity affects the perceived spatial concordance between the intratumoural patterns of cell proliferation and 18F-fluorothymidine uptake
DOI: 10.1016/j.radonc.2012.02.011
Abstract: Background and purpose: PET imaging with 18F-fluorothymidine (18F-FLT) can potentially be used to identify tumour subvolumes for selective dose escalation in radiation therapy. The purpose o...
|
Marian Axente,
Jun He,
Christopher P. Bass,
Jerry I. Hirsch,
Gobalakrishnan Sundaresan,
Jeffrey Williamson,
Jamal Zweit,
Andrei Pugachev
et al.
|
Full-length article
(In Press Corrected Proof)
|
23 March 2012 |
|
Adaptive radiotherapy for long course neo-adjuvant treatment of rectal cancer
DOI: 10.1016/j.radonc.2012.02.013
Abstract: Purpose: To quantify the potential margin reduction with adaptive radiotherapy (ART) during neo-adjuvant treatment of locally-advanced rectal cancer. Methods and materials: Repeat CT scans w...
|
Jasper Nijkamp,
Corrie Marijnen,
Marcel van Herk,
Baukelien van Triest,
Jan-Jakob Sonke
et al.
|
Full-length article
(In Press Corrected Proof)
|
23 March 2012 |
|
Programmable segmented volumetric modulated arc therapy for respiratory coordination in pancreatic cancer
DOI: 10.1016/j.radonc.2012.02.005
Abstract: We programmably divided long-arc volumetric modulated arc therapy (VMAT) into split short arcs, each taking less than 30s for respiratory coordination. The VMAT plans of five pancreatic canc...
|
Jian-Kuen Wu,
Chien-Jang Wu,
Jason Chia-Hsien Cheng
|
Short communication
(In Press Corrected Proof)
|
14 March 2012 |
|
Quantifying motion for pancreatic radiotherapy margin calculation
DOI: 10.1016/j.radonc.2012.02.012
Abstract: Background and purpose: Pancreatic radiotherapy (RT) is limited by uncertain target motion. We quantified 3D patient/organ motion during pancreatic RT and calculated required treatment margi...
|
Gillian Whitfield,
Pooja Jain,
Melanie Green,
Gillian Watkins,
Ann Henry,
Julie Stratford,
Ali Amer,
Thomas Marchant,
Christopher Moore,
Patricia Price
et al.
|
Full-length article
(In Press Corrected Proof)
|
14 March 2012 |
|
Salvage stereotactic reirradiation using the CyberKnife for the local recurrence of nasal or paranasal carcinoma
DOI: 10.1016/j.radonc.2012.01.017
Abstract: Purpose: To evaluate the clinical outcome of stereotactic reirradiation using the CyberKnife system for recurrent nasal or paranasal carcinoma. Materials and methods: From May 2005 to Februa...
|
Hiromitsu Iwata,
Koshi Tatewaki,
Mitsuhiro Inoue,
Naoki Yokota,
Kengo Sato,
Yuta Shibamoto
et al.
|
Full-length article
(In Press Corrected Proof)
|
07 March 2012 |
|
Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma
DOI: 10.1016/j.radonc.2011.12.031
Abstract: Background and purpose: Patients with recurrent or primary refractory Hodgkin lymphoma (HL) treated with high dose chemotherapy (HDT) and autologous stem cell transplant (ASCT) commonly rela...
|
Tithi Biswas,
Eva Culakova,
Jonathan W. Friedberg,
Jennifer L. Kelly,
Sughosh Dhakal,
Jane Liesveld,
Gordon L. Phillips,
Louis S. Constine
et al.
|
Full-length article
(In Press Corrected Proof)
|
07 March 2012 |
|
Dosimetric predictors of chest wall pain after lung stereotactic body radiotherapy
DOI: 10.1016/j.radonc.2012.01.014
Abstract: Purpose: To identify risk factors for the development of chest wall (CW) pain after thoracic stereotactic body radiotherapy (SBRT). Methods and materials: A registry of patients with lung le...
|
Kimberly M. Creach,
Issam El Naqa,
Jeffrey D. Bradley,
Jeffrey R. Olsen,
Parag J. Parikh,
Robert E. Drzymala,
Charles Bloch,
Clifford G. Robinson
et al.
|
Full-length article
(In Press Corrected Proof)
|
02 March 2012 |
|
Ensuring the integrity of treatment parameters throughout the radiotherapy process
DOI: 10.1016/j.radonc.2012.01.004
Abstract: Background and purpose: Ensuring data integrity in radiotherapy is of major importance and a complex task. The aim of this study was to compare three different combinations of treatment plan...
|
Fredrik Nordström,
Crister Ceberg,
Sven Å.J. Bäck
|
Full-length article
(In Press Corrected Proof)
|
20 February 2012 |
|
Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
DOI: 10.1016/j.radonc.2011.12.022
Abstract: Background and purpose: Concurrent chemoradiotherapy (CRT) confers survival benefit over radiotherapy (RT) alone in the treatment of locoregionally advanced nasopharyngeal carcinoma (NPC). T...
|
Herbert H. Loong,
Brigette B.Y. Ma,
Sing-Fai Leung,
Frankie Mo,
Edwin P. Hui,
Michael K. Kam,
Stephen L. Chan,
Brian K.H. Yu,
Anthony T.C. Chan
et al.
|
Full-length article
(In Press Corrected Proof)
|
02 February 2012 |
|
Out-of-field contributions for IMRT and volumetric modulated arc therapy measured using gafchromic films and compared to calculations using a superposition/convolution based treatment planning system
DOI: 10.1016/j.radonc.2011.12.030
Abstract: Purpose: To quantify the whole-body-dose delivered during the application of new techniques and compare them to the results obtained by treatment planning systems. The ultimate goal being th...
|
Frank Van den Heuvel,
Gilles Defraene,
Wouter Crijns,
Ria Bogaerts
|
Full-length article
(In Press Corrected Proof)
|
02 February 2012 |
|
Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma
DOI: 10.1016/j.radonc.2011.12.028
Abstract: Background and purpose: We sought to evaluate the nature and frequency of late toxicities in a cohort of nasopharyngeal cancer (NPC) patients treated with conventional radiotherapy alone. Me...
|
Jeffrey Kit Loong Tuan,
Tam Cam Ha,
Whee Sze Ong,
Tian Rui Siow,
Ivan Weng Keong Tham,
Swee Peng Yap,
Terence Wee Kiat Tan,
Eu Tiong Chua,
Kam Weng Fong,
Joseph Tien Seng Wee
et al.
|
Full-length article
(In Press Corrected Proof)
|
27 January 2012 |
|
Multivariate modeling of complications with data driven variable selection: Guarding against overfitting and effects of data set size
DOI: 10.1016/j.radonc.2011.12.006
Abstract: Purpose: Multivariate modeling of complications after radiotherapy is frequently used in conjunction with data driven variable selection. This study quantifies the risk of overfitting in a d...
|
Arjen van der Schaaf,
Cheng-Jian Xu,
Peter van Luijk,
Aart A. van’t Veld,
Johannes A. Langendijk,
Cornelis Schilstra
et al.
|
Full-length article
(In Press Corrected Proof)
|
24 January 2012 |
|
Hypofraction radiotherapy of liver tumor using cone beam computed tomography guidance combined with active breath control by long breath-holding
DOI: 10.1016/j.radonc.2011.11.007
Abstract: Background and purpose: To evaluate the feasibility and validity of cone beam computed tomography (CBCT) and active breath control (ABC) by long breath-holding in hypofraction radiotherapy o...
|
Renming Zhong,
Jin Wang,
Xiaoqin Jiang,
Yinbo He,
Hong Zhang,
Nianyong Chen,
Sen Bai,
Feng Xu
et al.
|
Full-length article
(In Press Corrected Proof)
|
20 January 2012 |
|
Bone marrow transplantation enhances trafficking of host-derived myelomonocytic cells that rescue intestinal mucosa after whole body radiation
DOI: 10.1016/j.radonc.2011.12.003
Abstract: Background: Bone marrow (BM)-derived cells were demonstrated within intestines after radiation damage and were reported to be responsible for intestine repair. However, there was a discrepan...
|
Hui-Ju Ch’ang,
Li-Mei Lin,
Pu-Yuan Chang,
Chi-Wen Luo,
Ya-Hui Chang,
Chuan-Kai Chou,
Helen H. Chen
et al.
|
Full-length article
(In Press Corrected Proof)
|
19 January 2012 |
|
Dose volume histogram analysis of focal liver reaction in follow-up multiphasic CT following stereotactic body radiotherapy for small hepatocellular carcinoma
DOI: 10.1016/j.radonc.2011.12.008
Abstract: Purpose: To investigate threshold dose (TD) of focal liver reaction (FLR) following stereotactic body radiotherapy (SBRT) for patients with hepatocellular carcinoma (HCC) and liver cirrhosis...
|
Atsuya Takeda,
Yohei Oku,
Naoko Sanuki,
Etsuo Kunieda,
Naoyoshi Koike,
Yousuke Aoki,
Toshio Ohashi,
Shogo Iwabuchi,
Kentaro Takatsuka,
Toshiaki Takeda,
Akitomo Sugawara
et al.
|
Full-length article
(In Press Corrected Proof)
|
16 January 2012 |
|
Stereotactic body radiation therapy in the treatment of multiple primary lung cancers
DOI: 10.1016/j.radonc.2011.12.005
Abstract: Background and purpose: Patients with multiple primary lung cancers (MPLC) present a therapeutic dilemma, particularly when they are at high risk for surgical resection. We evaluated the rol...
|
Kimberly M. Creach,
Jeffrey D. Bradley,
Pawinee Mahasittiwat,
Clifford G. Robinson
|
Full-length article
(In Press Corrected Proof)
|
16 January 2012 |
|
Volumetric modulated arc therapy for nasopharyngeal carcinoma: A dosimetric comparison with TomoTherapy and step-and-shoot IMRT
DOI: 10.1016/j.radonc.2011.11.017
Abstract: Purpose: Volumetric modulated arc therapy (VMAT), a novel technique, employs a linear accelerator to conduct dynamic modulation rotation radiotherapy. The goal of this study was to compare V...
|
Szu-Huai Lu,
Jason Chia-Hsien Cheng,
Sung-Hsin Kuo,
Jason Jeun-Shenn Lee,
Liang-Hsin Chen,
Jian-Kuen Wu,
Yu-Hsuan Chen,
Wan-Yu Chen,
Shu-Yu Wen,
Fok-Ching Chong,
Chien-Jang Wu,
Chun-Wei Wang
et al.
|
Full-length article
(In Press Corrected Proof)
|
11 January 2012 |
|
The International Atomic Energy Agency (IAEA): An active role in the global fight against cancer
DOI: 10.1016/j.radonc.2011.10.004
The International Atomic Energy Agency (IAEA) is an independent, intergovernmental science and technology-based organization, in the United Nations, that serves as the global focal point for nuclear c...
|
Eduardo Rosenblatt,
Eduardo Zubizarreta,
Jan Wondergem,
Elena Fidarova,
Joanna Izewska
et al.
|
Editorial
(In Press Corrected Proof)
|
14 December 2011 |
|
External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy
DOI: 10.1016/j.radonc.2011.11.006
Abstract: Purpose: The purpose of this study was to investigate the ability of predictive models for patient-rated xerostomia (XER6M) and sticky saliva (STIC6M) at 6months after completion of primary ...
|
Ivo Beetz,
Cornelis Schilstra,
Peter van Luijk,
Miranda E.M.C. Christianen,
Patricia Doornaert,
Henk P. Bijl,
Olga Chouvalova,
Edwin R. van den Heuvel,
Roel J.H.M. Steenbakkers,
Johannes A. Langendijk
et al.
|
Full-length article
(In Press Corrected Proof)
|
14 December 2011 |
|
Does IGRT ensure target dose coverage of head and neck IMRT patients?
DOI: 10.1016/j.radonc.2011.09.024
Abstract: Purpose: To determine if image-guided radiotherapy (IGRT) ensures dose coverage to the target, and to assess the dosimetric impact of anatomic changes using megavoltage cone-beam CT (MVCBCT)...
|
Pierre Graff,
Weigang Hu,
Sue S. Yom,
Jean Pouliot
|
Full-length article
(In Press Corrected Proof)
|
07 December 2011 |
|
Combination of quercetin with radiotherapy enhances tumor radiosensitivity in vitro and in vivo
DOI: 10.1016/j.radonc.2011.10.023
Abstract: Purpose: Quercetin (3, 3,′ 4′, 5, 7 – five-flavonoids) is one of the main components of flavonoids, with multifunctions on immune function, anti-oxidation, anti-viral, anti-inflammatory, and...
|
Chenghe Lin,
Yan Yu,
Hong-guan Zhao,
Aimin Yang,
Hong Yan,
Yali Cui
et al.
|
Full-length article
(In Press Corrected Proof)
|
28 November 2011 |
|
The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China
DOI: 10.1016/j.radonc.2011.10.009
Abstract: Purpose: To evaluate the 7th edition of the International Union against Cancer/American Joint Committee on Cancer (UICC/AJCC) staging system for nasopharyngeal carcinoma (NPC) in patients tr...
|
Lei Chen,
Yan-Ping Mao,
Fang-Yun Xie,
Li-Zhi Liu,
Ying Sun,
Li Tian,
Ling-Long Tang,
Ai-Hua Lin,
Li Li,
Jun Ma
et al.
|
Full-length article
(In Press Corrected Proof)
|
21 November 2011 |
|
Erratum to “Time course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors” [Radiother. Oncol. 99 (2011) 23–28]
DOI: 10.1016/j.radonc.2011.10.001
The Publisher regrets that in the above published article the authors’ first and family names appeared in reverse order. The authors’ names are presented in the correct order above.
|
Sara Madaschi,
Claudio Fiorino,
Marco Losa,
Roberto Lanzi,
Elena Mazza,
Micaela Motta,
Lucia Perna,
Elena Brioschi,
Marina Scavini,
Michele Reni
et al.
|
Erratum
(In Press Corrected Proof)
|
07 November 2011 |
|
Second cancer after radiotherapy, 1981–2007
DOI: 10.1016/j.radonc.2011.09.013
Abstract: Background and purpose: Today, there is growing concern about radiotherapy induced secondary malignancies. We analysed the incidence and dose dependence of second cancer. Material and method...
|
Detlef Bartkowiak,
Nicole Humble,
Peter Suhr,
Juliane Hagg,
Katharina Mair,
Bernd Polivka,
Uwe Schneider,
Dirk Bottke,
Thomas Wiegel
et al.
|
Full-length article
(In Press Corrected Proof)
|
12 October 2011 |
|
Predictive modelling for swallowing dysfunction after primary (chemo)radiation: Results of a prospective observational study
DOI: 10.1016/j.radonc.2011.08.009
Abstract: Background and purpose: The purpose of this large multicentre prospective cohort study was to identify which dose volume histogram parameters and pre-treatment factors are most important to ...
|
Miranda E.M.C. Christianen,
Cornelis Schilstra,
Ivo Beetz,
Christina T. Muijs,
Olga Chouvalova,
Fred R. Burlage,
Patricia Doornaert,
Phil W. Koken,
C. René Leemans,
Rico N.P.M. Rinkel,
Marieke J. de Bruijn,
G.H. de Bock,
Jan L.N. Roodenburg,
Bernard F.A.M. van der Laan,
Ben J. Slotman,
Irma M. Verdonck-de Leeuw,
Hendrik P. Bijl,
Johannes A. Langendijk
et al.
|
Full-length article
(In Press Corrected Proof)
|
12 September 2011 |
|
Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: The role of dosimetric and clinical factors
DOI: 10.1016/j.radonc.2011.05.010
Abstract: Purpose: The purpose of this multicentre prospective study was to investigate the significance of the radiation dose in the major and minor salivary glands, and other pre-treatment and treat...
|
Ivo Beetz,
Cornelis Schilstra,
Fred R. Burlage,
Phil W. Koken,
Patricia Doornaert,
Henk P. Bijl,
Olga Chouvalova,
C. René Leemans,
Geertruida H. de Bock,
Miranda E.M.C. Christianen,
Bernard F.A.M. van der Laan,
Arjan Vissink,
Roel J.H.M. Steenbakkers,
Johannes A. Langendijk
et al.
|
Full-length article
(In Press Corrected Proof)
|
01 June 2011 |
|
REMOVED: Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase 2 study evaluating a prolonged high dose of boronophenylalanine (BPA)
DOI: 10.1016/j.radonc.2006.04.001
This article has been removed consistent with Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). The Publisher apologizes for any inconvenience this may cause.
|
Roger Henriksson,
Jacek Capala,
Britta H-Stenstam,
Annika Michanek,
Sten-Åke Lindahl,
Leif Salford,
Lars Franzén,
Erik Blomquist,
Jan-Erik Westlin,
A. Tommy Bergenheim
et al.
|
Removal
(In Press Corrected Proof)
|
24 May 2006 |
|
REMOVED: Boron neutron capture therapy in the treatment of glioblastoma: As effective, more effective or less effective than photon irradiation?
DOI: 10.1016/j.radonc.2006.01.011
This article has been removed, consistent with Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). The Publisher apologizes for any inconvenience this may cause.
|
Rolf F. Barth,
Heikki Joensuu
|
Removal
(In Press Corrected Proof)
|
09 May 2006 |